Protalix BioTherapeutics
PLX
#8349
Rank
NZ$0.38 B
Marketcap
NZ$4.73
Share price
6.11%
Change (1 day)
4.46%
Change (1 year)

EPS for Protalix BioTherapeutics (PLX)

EPS in 2025 (TTM): NZ$0.02662

According to Protalix BioTherapeutics 's latest financial reports the company's current EPS (TTM) is NZ$0.03300. In 2024 the company made an earnings per share (EPS) of NZ$0.06600 a decrease over its 2023 EPS that were of NZ$0.20.

EPS history for Protalix BioTherapeutics from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$0.02662-59.66%
2024NZ$0.06600-66.67%
2023NZ$0.20-138.71%
2022NZ-$0.51-50%
2021NZ-$1.02181.82%
2020NZ-$0.36-82.11%
2019NZ-$2.03-31.67%
2018NZ-$2.97-72.31%
2017NZ-$10.72124.14%
2016NZ-$4.78-147.54%
2015NZ$10.06-290.63%
2014NZ-$5.286.67%
2013NZ-$4.95130.77%
2012NZ-$2.14-69.77%
2011NZ-$7.0919.44%
2010NZ-$5.94-12.2%
2009NZ-$6.7636.67%
2008NZ-$4.95-37.5%
2007NZ-$7.9250%
2006NZ-$5.283.23%
2005NZ-$5.11138.46%
2004NZ-$2.14-74%
2003NZ-$8.25-0%
2002NZ-$8.25-50%
2001NZ-$16.50233.33%
2000NZ-$4.95-84.21%
1999NZ-$31.35-24%
1998NZ-$41.25-600%
1997NZ$8.25-16.67%
1996NZ$9.90

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
NZ$2.24 6,700.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
NZ$7.11 21,450.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
NZ-$0.18-650.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$2.05 6,100.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel